Showing results (1341-1350 of 2,132) with videos related to
Sort By:
Pageof 214
Biopharmaceutics & Drug Disposition|November 1, 1994
Repeated dose pharmacokinetics of pancopride in human volunteersP Salva, J Costa, A Pérez-Campos, et al.Biopharmaceutics & Drug Disposition|November 1, 1994
The effect of different routes of administration on the metabolism of morphine: the disposition of morphine and its metabolites after topical applicationT Matsuzawa, Y Wada, M Shimoyama, et al.Biopharmaceutics & Drug Disposition|December 1, 1994
Comparative pharmacokinetics of oxaliplatin (L-OHP) and carboplatin (CBDCA) in mice with reference to circadian dosing timeN A Boughattas, B Hecquet, C Fournier, et al.Biopharmaceutics & Drug Disposition|April 1, 1994
Pharmacokinetics and pharmacodynamics of furosemide after intravenous and oral administration to spontaneously hypertensive rats and DOCA-salt-induced hypertensive ratsS H Jang, M G Lee, N D KimBiopharmaceutics & Drug Disposition|April 1, 1994
Pharmacokinetics and pharmacodynamics of a slow-release formulation of diltiazem after the administration of a single and repeated doses to healthy volunteersM Lefebvre, Y Lacasse, J Spénard, et al.Biopharmaceutics & Drug Disposition|April 1, 1994
A single-dose comparison of the bioavailability of aluminium from two formulations of sucralphate in normal volunteersE L Conway, C O'Callaghan, O H Drummer, et al.Biopharmaceutics & Drug Disposition|April 1, 1984
Pharmacokinetics of valpromide in dogs after various modes of administrationM Bialer, A RubinsteinBiopharmaceutics & Drug Disposition|April 1, 1983
Antipyrine metabolite kinetics in rats: studies on dose and time dependenceJ C Rhodes, J B HoustonBiopharmaceutics & Drug Disposition|April 1, 1983
Valproic acid pharmacokinetics in the mouse following controlled-release of pharmacologic and toxic doses via novel implantable and refillable drug reservoirsH Nau, P Finley, J Williams, et al.Biopharmaceutics & Drug Disposition|January 1, 1983
Pharmacokinetics of two lorazepam formulations, oral and sublingual, after multiple dosesG Caillé, J Spénard, Y Lacasse, et al.Pageof 214